Yoon Seokho Bryan's Form 4 filing
Terns Pharmaceuticals, Inc. (TERN) · filed Feb 3, 2023
- Accession no.
- 0001562180-23-000983
- Filed
- Feb 3, 2023
- Trade date
- Nov 30, 2022-Feb 1, 2023
- Filing delay
- 65 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction and 1 derivative transaction. Open-market purchases total $4.23. It was filed 65 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Yoon Seokho BryanCIK 0001761164 | Officer (COO and General Counsel) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 30, 2022 | Common Stock | PPurchaseAcquired | +3 | $1.41 | +$4.23 | 7,659 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2023 | Common Stock | AGrant or awardAcquired | +360,000 | $0.00 | $0 | 360,000 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.